|
Nicotine Related Compound B (20 mg) (3-(1-methyl-1H-pyrrol-2-yl)pyridine) |
487-19-4 |
1463337 |
USP |
詳細を見る
|
|
Nicotine Related Compound C (20 mg) ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-… |
486-56-6 |
1463348 |
USP |
詳細を見る
|
|
Nicotine Related Compound D (20 mg) (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fum… |
N/A |
1463359 |
USP |
詳細を見る
|
|
Nicotine Related Compound E (20 mg) ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolid… |
N/A |
1463360 |
USP |
詳細を見る
|
|
Nicotine Related Compound F (20 mg) (3-(pyrrolidin-2-yl)pyridine) |
5746-86-1 |
1463371 |
USP |
詳細を見る
|
|
Nicotine Related Compound G (20 mg) ((S)-3-(piperidin-2-yl)pyridine) |
494-52-0 |
1463382 |
USP |
詳細を見る
|
|
Nifedipine (125 mg) |
21829-25-4 |
1463508 |
USP |
詳細を見る
|
|
Nifedipine Nitrophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrophenyl)-2,6-d… |
67035-22-7 |
1463600 |
USP |
詳細を見る
|
|
Nifedipine Nitrosophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrosophenyl)-2… |
50428-14-3 |
1463701 |
USP |
詳細を見る
|
|
Neomycin Sulfate System Suitability Mixture (100 mg) |
N/A |
1458031 |
USP |
詳細を見る
|
